|
|
|
|
|
1
|
Biotechnology Sector |
Nov 2009 |
$129.00 |
|
The US biotechnology industry includes about 1,500 companies with combined annual revenue of about $70 billion. Major companies include Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), Genzyme, Life Technologies, and Monsanto. Because many drugs
more...
Published by: First Research, Inc.
| Search inside this report |
|
|
2
|
Monoclonal antibodies: 2009 update |
Nov 2009 |
$7,600.00 |
|
Introduction The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2014 and assessing trends by product, company, therapy area, geography, technology and target type. It also
more...
Published by: Datamonitor
|
|
|
3
|
Dealmaking and Industry Outlook: Neurological Disease |
Nov 2009 |
$2,250.00 |
|
The plethora of recent reports of new genes and pathways linked to neurological diseases shows that the underlying
causes of these diseases are far from certain; as a result, therapeutic strategies in effect today may
more...
Published by: Decision Resources
|
|
|
4
|
Biotechnology (Pharmaceuticals) Report |
Nov 2009 |
$1,500.00 |
|
The Global Biotechnology Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation
more...
Published by: Plimsoll Publishing Ltd.
|
|
|
5
|
Three Bundled Reports 1: Dextrins: Food & Industrial 2: CWS (cold water swelling) / Spray Cooked starches 3: Physically Modified Starches each with Applications, Products and Markets |
Nov 2009 |
$3,850.00 |
|
The three starch derivatives cover the most active areas of food ingredients to meet the growth of convenience, snacks, clean labeling.
Dextrin Report Dextrins belong to a class of low-molecular-weight carbohydrates degradation products made from
more...
Published by: S. K. Patil and Associates
|
|
|
6
|
Global Stem Cell and Advanced Technologies Market |
Nov 2009 |
$4,650.00 |
|
The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and
more...
Published by: MarketsandMarkets
| Search inside this report |
|
|
7
|
Opportunities in Human Embryonic Stem Cell (hESC) Products |
Nov 2009 |
$3,495.00 |
|
Human embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, which is a stage reach 4-5 days post fertilization. They are the most pluripotent of all stem cell
more...
Published by: BioInformant Worldwide, L.L.C.
| Search inside this report |
|
|
8
|
Physically Modified Starches Applications, Products and Markets |
Nov 2009 |
$975.00 |
|
Recent developments in starch technology are the development and marketing of physically modified starches that perform similar to chemically modified starches in food applications. National led this development by introducing product line under brand
more...
Published by: S. K. Patil and Associates
|
|
|
9
|
Algae For Fuel, Algal Oil, Biofuels, Biodiesel, Ethanol And The Future Of Petroleum And Green Energy |
Nov 2009 |
$2,900.00 |
|
This research provides an overview on what could become one of the most significant technological and economic events of the early 21st century: turning algae into fuel, i.e. algal oil, on a commercial scale. If
more...
Published by: Amadee & Company
| Search inside this report |
|
|
10
|
Dextrins Food & Industrial applications, Products & Markets |
Nov 2009 |
$2,900.00 |
|
Dextrins belong to a class of low-molecular-weight carbohydrates degradation products made from starch manufactured by a process called pyrolysis. During pyrolysis, dry, powdered starch is treated with acid in a suitable reactor and heated
more...
Published by: S. K. Patil and Associates
|
|
|
11
|
CWS (cold water swelling) / Spray Cooked starches - Applications, Products and Markets |
Nov 2009 |
$975.00 |
|
Cold water swelling and spray cooked starches are marketed heavily for instant preparation and convenience aspects of food preparation. Granular cold water swelling/soluble starches are produced by treatment with an alcohol and a strong base
more...
Published by: S. K. Patil and Associates
|
|
|
12
|
Freedonia Focus on Biologicals |
Oct 2009 |
$500.00 |
|
This report discusses US biologicals demand for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, product and market segmentation, technological and product development, regulatory considerations, market environment,
more...
Published by: Freedonia Focus
|
|
|
13
|
Crop Protection China Market Opportunities and Challenges |
Oct 2009 |
$8,150.00 |
|
China is a traditional agricultural country, with a total area of 5,000 billion square meters stricken by plant diseases and insect pests each year. With only 7% of the world’s arable land, China has fed
more...
Published by: CCM International Limited
|
|
|
14
|
Protein Kinase Therapeutics in Oncology - Where to Commercialize? |
Oct 2009 |
$3,500.00 |
|
This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extensively analyses 133 identified targets of
more...
Published by: BioSeeker Group AB
|
|
|
15
|
Acorda Therapeutics, Inc. - SWOT Analysis |
Oct 2009 |
$125.00 |
|
Datamonitor's Acorda Therapeutics, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Acorda Therapeutics, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and
more...
Published by: Datamonitor
| Search inside this report |
|
|
16
|
Future of Green Biotechnology in China |
Oct 2009 |
$6,650.00 |
|
This report is the unique and latest one available in the world to provide good understanding about Green Biotechnology (GB) in China and to find out business opportunities in this field. The first edition of
more...
Published by: CCM International Limited
|
|
|
17
|
Biotechnology in the US - Industry Risk Rating Report |
Oct 2009 |
$825.00 |
|
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Biotechnology in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business
more...
Published by: IBISWorld
| Search inside this report |
|
|
18
|
Biotechnology in Australia - Industry Risk Rating Report |
Oct 2009 |
$810.00 |
|
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Biotechnology in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating
more...
Published by: IBISWorld
| Search inside this report |
|
|
19
|
Scientific Research in Australia - Industry Risk Rating Report |
Oct 2009 |
$810.00 |
|
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Scientific Research in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business
more...
Published by: IBISWorld
| Search inside this report |
|
|
20
|
Plunkett's Health Care Technologies Overview 2010 (Summary) |
Oct 2009 |
$199.99 |
|
This summary contains the complete technologies section excerpted from the highly-acclaimed Plunkett's Health Care Industry Almanac. This report will be your ready-reference guide to new and developing health care technologies. Technology topics range from stem
more...
Published by: Plunkett Research, Ltd.
| Search inside this report |
|
|
21
|
Crucell N.V. - SWOT Analysis |
Oct 2009 |
$125.00 |
|
Datamonitor's Crucell N.V. - SWOT Analysis company profile is the essential source for top-level company data and information. Crucell N.V. - SWOT Analysis examines the company’s key business structure and operations, history and products, and
more...
Published by: Datamonitor
| Search inside this report |
|
|
22
|
Elan Corporation, plc - SWOT Analysis |
Oct 2009 |
$125.00 |
|
Datamonitor's Elan Corporation, plc - SWOT Analysis company profile is the essential source for top-level company data and information. Elan Corporation, plc - SWOT Analysis examines the company’s key business structure and operations, history and
more...
Published by: Datamonitor
| Search inside this report |
|
|
23
|
Biotechnology: Global Industry Guide |
Oct 2009 |
$1,495.00 |
|
Datamonitor's Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive
more...
Published by: Datamonitor
| Search inside this report |
|
|
24
|
The Human Genome Sequencing Center at Baylor College of Medicine Relies on Quantum's StorNext Software for Data Management |
Oct 2009 |
$3,500.00 |
|
This IDC Buyer Case Study examines how one research institution utilizes Quantum's StorNext data management software to support its growing storage
more...
Published by: IDC
| Search inside this report |
|
|
25
|
Lonza Group Ltd - SWOT Analysis |
Oct 2009 |
$125.00 |
|
Datamonitor's Lonza Group Ltd - SWOT Analysis company profile is the essential source for top-level company data and information. Lonza Group Ltd - SWOT Analysis examines the company’s key business structure and operations, history and
more...
Published by: Datamonitor
| Search inside this report |
|
|
|
|
|
0 items
